Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03343080 · ClinicalTrials.gov registry record · Phase 2
Lidocaine as an Endotracheal Tube (ETT) Cuff Media
A Phase 2 study of Cardiac Disease, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT03343080: Completed Phase 2 study of Cardiac Disease, sponsored by Mayo Clinic.
NCT03343080 is a Phase 2 study of Cardiac Disease that has completed, run by Mayo Clinic. The registered enrollment target is 32 participants, below the 821-participant average among 24 other Cardiac Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03343080, a Phase 2 study of Cardiac Disease, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers will compare the effects of lidocaine versus air, as a way to fill the breathing tube cuff which is gently inflated to hold in place the trachea (airway) during surgery. Air is the traditional method used to inflate the breathing tube cuff. Researchers wish to find if lidocaine works better than air to facilitate tolerance to the breathing tube (decreased coughing, sore throat, hoarseness). They also want to learn more about its effectiveness for this particular surgical intervention.
Conditions Studied
Interventions
- OTHER Air
- DRUG 1.8% lidocaine plus 0.76% sodium bicarbonate
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2018-07-27 |
| Est. Completion | 2019-08-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03343080
The ClinicalTrials.gov registry entry for NCT03343080 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 821-participant average among 24 other Cardiac Disease trials with a reported enrollment target (96% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiac Disease appearing as the primary indexed condition, and to 2 interventions - of which Air is the first listed.
NCT03343080 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT03343080 about?
NCT03343080 is a clinical study titled "Lidocaine as an Endotracheal Tube (ETT) Cuff Media". Researchers will compare the effects of lidocaine versus air, as a way to fill the breathing tube cuff which is gently inflated to hold in place the trachea (airway) during surgery. Air is the traditional method used to inflate the breathing tube cuff. Researchers wish to find if lidocaine works bet...
What is the current status of trial NCT03343080?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2018-07-27. Estimated completion is 2019-08-01.
What conditions does trial NCT03343080 study?
This clinical trial studies the following conditions: Cardiac Disease.
What interventions are being tested in trial NCT03343080?
The interventions under investigation include: Air (OTHER), 1.8% lidocaine plus 0.76% sodium bicarbonate (DRUG).
Who is sponsoring clinical trial NCT03343080?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03343080 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery
RECRUITING · Phase 2
-
Cardiac Performance System Data Collection Study - Minnesota
RECRUITING
-
A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening
RECRUITING
-
Fresh Autologous Whole Blood Transfusion After Cardiopulmonary Bypass
RECRUITING · NA
-
Rectus Sheath Block in Cardiac Surgery
RECRUITING · NA
-
Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
RECRUITING
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.